John Hester
Stock Analyst at Bell Potter
(4.12)
# 1,703
Out of 4,668 analysts
215
Total ratings
48%
Success rate
10.2%
Average return
Main Sectors:
Stocks Rated by John Hester
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $19.00 | $15.62 | +21.64% | 33 | Aug 20, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $226.00 | $191.60 | +17.95% | 16 | Aug 19, 2026 | |
| ASX: DOC Doctor Care Anywhere Group PLC | Maintained: Buy | $0.24 → $0.22 | $0.12 | +83.33% | 5 | Aug 18, 2026 | |
| ASX: AVR Anteris Technologies Global Corp. | Downgraded: Hold | $13.00 | $12.63 | +2.93% | 5 | Aug 12, 2026 | |
| ASX: CU6 Clarity Pharmaceuticals Ltd | Maintained: Buy | $6.50 → $6.40 | $2.48 | +158.06% | 20 | Aug 10, 2026 | |
| ASX: PAR Paradigm Biopharmaceuticals Limited | Maintained: Buy | $0.45 → $0.42 | $0.18 | +140.00% | 11 | Aug 3, 2026 | |
| ASX: PNV PolyNovo Limited | Downgraded: Hold | $1.80 → $1.00 | $1.07 | -6.54% | 12 | Jul 24, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Maintained: Hold | $3.00 | $2.90 | +3.45% | 5 | Jul 19, 2026 | |
| ASX: MSB Mesoblast Limited | Upgraded: Buy | $4.45 | $2.36 | +88.56% | 20 | Jul 12, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Maintained: Buy | $1.09 | $0.57 | +91.23% | 7 | Jul 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.00 | $0.50 | +102.02% | 14 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1.65 → $1.75 | $1.55 | +13.27% | 2 | Jul 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.30 → $0.17 | $0.14 | +21.43% | 17 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.50 → $6.00 | $3.83 | +56.66% | 13 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.25 | $0.08 | +204.88% | 7 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $4.10 → $3.60 | $3.63 | -0.83% | 16 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.05 → $0.06 | $0.01 | +500.00% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.18 → $0.15 | $0.02 | +733.33% | 2 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.01 | $0.01 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.78 → $3.78 | $4.42 | n/a | 3 | Nov 25, 2022 |
Telix Pharmaceuticals Limited
Aug 20, 2026
Maintained: Buy
Price Target: $19.00
Current: $15.62
Upside: +21.64%
Pro Medicus Limited
Aug 19, 2026
Maintained: Buy
Price Target: $226.00
Current: $191.60
Upside: +17.95%
Doctor Care Anywhere Group PLC
Aug 18, 2026
Maintained: Buy
Price Target: $0.24 → $0.22
Current: $0.12
Upside: +83.33%
Anteris Technologies Global Corp.
Aug 12, 2026
Downgraded: Hold
Price Target: $13.00
Current: $12.63
Upside: +2.93%
Clarity Pharmaceuticals Ltd
Aug 10, 2026
Maintained: Buy
Price Target: $6.50 → $6.40
Current: $2.48
Upside: +158.06%
Paradigm Biopharmaceuticals Limited
Aug 3, 2026
Maintained: Buy
Price Target: $0.45 → $0.42
Current: $0.18
Upside: +140.00%
PolyNovo Limited
Jul 24, 2026
Downgraded: Hold
Price Target: $1.80 → $1.00
Current: $1.07
Upside: -6.54%
Sigma Healthcare Limited
Jul 19, 2026
Maintained: Hold
Price Target: $3.00
Current: $2.90
Upside: +3.45%
Mesoblast Limited
Jul 12, 2026
Upgraded: Buy
Price Target: $4.45
Current: $2.36
Upside: +88.56%
Aroa Biosurgery Limited
Jul 12, 2026
Maintained: Buy
Price Target: $1.09
Current: $0.57
Upside: +91.23%
Jul 6, 2026
Maintained: Buy
Price Target: $1.00
Current: $0.50
Upside: +102.02%
Jul 3, 2026
Downgraded: Hold
Price Target: $1.65 → $1.75
Current: $1.55
Upside: +13.27%
Jun 2, 2026
Downgraded: Hold
Price Target: $0.30 → $0.17
Current: $0.14
Upside: +21.43%
Jun 2, 2026
Maintained: Buy
Price Target: $4.50 → $6.00
Current: $3.83
Upside: +56.66%
May 28, 2026
Maintained: Buy
Price Target: $0.25
Current: $0.08
Upside: +204.88%
Feb 24, 2026
Upgraded: Hold
Price Target: $4.10 → $3.60
Current: $3.63
Upside: -0.83%
Dec 17, 2025
Maintained: Buy
Price Target: $0.05 → $0.06
Current: $0.01
Upside: +500.00%
Sep 3, 2025
Downgraded: Hold
Price Target: $0.18 → $0.15
Current: $0.02
Upside: +733.33%
Dec 19, 2024
Downgraded: Hold
Price Target: $0.01
Current: $0.01
Upside: n/a
Nov 25, 2022
Maintained: Hold
Price Target: $4.78 → $3.78
Current: $4.42
Upside: n/a